Trial · NCT07899060
Safety and Efficacy of RashEndZ Wound Aeration Technology
NCT07899060, Not applicable, Terminated, RashEndZ Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of RashEndZ Wound Aeration Technology. Trials, record NCT07899060. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899060
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of RashEndZ Wound Aeration Technology
- NCT number
- NCT07899060
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 10 participants, actual
- Lead sponsor
- RashEndZ Inc.
- Conditions
- Incontinence-associated Dermatitis, Decubitus Ulcer
- Interventions
- Dynamic Oxygen Skin Therapy (DOST), Standard Wound Care
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Device-Related Adverse Events | Start of treatment until wound closure or discharge, up to 8 days | Count of participants with adverse events, including skin irritation or patient-reported discomfort, attributed to Dynamic Oxygen Skin Therapy (DOST) delivered via RashEndZ Wound Aeration Technology, recorded on daily assessment datasheets. |
| Primary | Number of Participants Who Discontinued DOST Due to Intolerance | Start of treatment until end of treatment, up to 8 days | Count of participants whose DOST treatment was stopped because side effects or adverse events required cessation of DOST and initiation of standard-of-care treatment, per the protocol definition of "poorly tolerated." |
| Secondary | Rate of Change in IADS Score per Treatment Day | Baseline (enrollment) to end of treatment, up to 8 days | Change from baseline in IADS score (range 0-52, lower scores indicate less severe IAD) divided by number of treatment days, to describe the time course of change in each group. |
| Secondary | Change From Baseline in IADS Score at End of Treatment | Baseline (enrollment) and end of treatment, up to 8 days | Incontinence-Associated Dermatitis Severity (IADS) score (Borchert et al., 2010; range 0-52, lower scores indicate less severe IAD) at end of treatment minus score at enrollment, reported descriptively for each group in participants with IAD. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899060
GET https://conductscience.org/api/trials/v1/NCT07899060/registered